Summary of high-quality studies comparing various equations for LDL-C calculation since 2020.
First author and Publication year . | Sample size . | Location . | LDL-C equations evaluated . | LDL-C reference method . | Baseline population . | Summary of findings . |
---|---|---|---|---|---|---|
Samuel C. et al. (8) 2023 | 5 051 467 | USA | 23 total equations including:
| VAP ultracentrifugation | Hyperlipidemia:
| Martin–Hopkins was most accurate, followed by the Sampson-NIH, Chen, and Puavilai equations. In addition to the highest overall accuracy, the Martin–Hopkins equation was the top performing equation when stratifying by age, sex, fasting status, and triglyceride levels, as well as in patients with atherosclerotic cardiovascular disease, hypertension, diabetes, kidney disease, inflammation, and thyroid dysfunction. |
Sun C. et al. (9) 2023 | 26 094 | Canada |
| Not applicable: study assessed discordance among LDL-C equations | Hyperlipidemia:
| Both the Martin–Hopkins and the Sampson-NIH equations reclassified patients with ↑ TG and ↓ LDL-C compared to Friedewald. However, the Sampson-NIH equation underestimated LDL-C in patients with FH. |
Martin S.S. et al. (10) 2023 | 364 | Netherlands and Denmark |
| Preparative ultracentrifugation (beta quantification) | Dyslipidemia patients on CETP inhibition in a multicenter randomized controlled trial | Martin–Hopkins was the most accurate, followed by the Sampson-NIH and Friedewald equations. Held true in patients with ↑ TG and ↓ LDL-C. |
Steyn N. et al. (11) 2023 | 64 765 | South Africa |
| Direct chemical assay | Adults with hypertriglyceridemia across 3 hospital sites | The Extended Martin–Hopkins equation correlated better with direct LDL-C than the Sampson-NIH equation on both platforms with TG levels up to 800 mg/dL (9.04 mmol/L). |
Ertürk Zararsız G. et al. (12) 2022 | 3908 | Turkey |
| Direct chemical assays (Roche, Beckman, Siemens) | Pediatric population (age <18 years) undergoing lipid testing | Martin–Hopkins and Extended Martin–Hopkins had the highest concordance coefficient in both overall and all sublevels of LDL-C, non-HDL-C, and TG. |
Naser A. et al. (13) 2022 | 402 | Brazil |
| Direct chemical assay | Patients with diabetes mellitus | Martin–Hopkins and Sampson-NIH equations showed similar accuracy for calculating LDL-C. (Martin–Hopkins 96.3% and Sampson-NIH 96.0% when compared to direct measurement). However, this study is limited by a relatively small sample size. |
Azimi V. et al. (14) 2022 | 934 | USA |
| Direct chemical assay | Adult outpatients and inpatients from a variety of specialties | Martin–Hopkins equation ↓ LDL-C treatment group miscategorization rates leading to ↓ underestimation of risk compared to the Sampson-NIH equation; however, neither was sufficiently accurate to report LDL-C in patients with ↑ TG ≥400 mg/dL (≥4.52 mmol/L). |
Song Y. et al. (15) 2022 | 177 111 | South Korea |
| Direct chemical assay | Asymptomatic adults who underwent lipid testing | Martin–Hopkins outperformed the Sampson-NIH equation with the lowest mean absolute differences across the full spectrum of TG levels, even up to TG values of 500–600 mg/dL (5.64–6.78 mmol/L). |
Sajja A. et al. (16) 2022 | 146 106 | Western USA |
| Not applicable: study assessed discordance between LDL-C equations | Adults with clinical ASCVD and at least 1 lipid panel with a TG level of <400 mg/dL | The Martin–Hopkins equation consistently estimated higher LDL-C values than the Friedewald and Sampson-NIH equations. Discordance rates were clinically meaningful [>10 mg/dL (0.26 mmol/L)], and highest at low LDL-C [<70 mg/dL (<1.81 mmol/L)] and TG levels ≥150 mg/dL (≥1.69 mmol/L). |
Steyn N. et al. (17) 2022 | 64 763 | South Africa |
| Direct chemical assay | Pediatric patients and adult patients with uncontrolled diabetes mellitus |
|
Rossouw H. et al. (18) 2021 | 9995 | South Africa | 11 total equations including:
| Direct chemical assays (Abbott and Roche) | Adult lipid samples analyzed by the Abbott and Roche analyzers | On the Abbott platform there was no difference between the Martin–Hopkins and Sampson-NIH methods; however, with the Roche assay, the Martin–Hopkins method outperformed the Sampson-NIH. The authors suggested the replacement of the Friedewald equation with Martin–Hopkins equation in clinical practice to improve the quality of LDL-C across analyzers, whereas caution was advised regarding the Sampson-NIH equation. |
Sajja A. et al. (7) 2021 | 111 939 | USA |
| VAP ultracentrifugation | Hyperlipidemia:
| The extended Martin–Hopkins equation showed greater LDL-C accuracy compared with the Friedewald and Sampson-NIH equations in patients with TG levels of 400 to 799 mg/dL (4.52–9.02 mmol/L). |
First author and Publication year . | Sample size . | Location . | LDL-C equations evaluated . | LDL-C reference method . | Baseline population . | Summary of findings . |
---|---|---|---|---|---|---|
Samuel C. et al. (8) 2023 | 5 051 467 | USA | 23 total equations including:
| VAP ultracentrifugation | Hyperlipidemia:
| Martin–Hopkins was most accurate, followed by the Sampson-NIH, Chen, and Puavilai equations. In addition to the highest overall accuracy, the Martin–Hopkins equation was the top performing equation when stratifying by age, sex, fasting status, and triglyceride levels, as well as in patients with atherosclerotic cardiovascular disease, hypertension, diabetes, kidney disease, inflammation, and thyroid dysfunction. |
Sun C. et al. (9) 2023 | 26 094 | Canada |
| Not applicable: study assessed discordance among LDL-C equations | Hyperlipidemia:
| Both the Martin–Hopkins and the Sampson-NIH equations reclassified patients with ↑ TG and ↓ LDL-C compared to Friedewald. However, the Sampson-NIH equation underestimated LDL-C in patients with FH. |
Martin S.S. et al. (10) 2023 | 364 | Netherlands and Denmark |
| Preparative ultracentrifugation (beta quantification) | Dyslipidemia patients on CETP inhibition in a multicenter randomized controlled trial | Martin–Hopkins was the most accurate, followed by the Sampson-NIH and Friedewald equations. Held true in patients with ↑ TG and ↓ LDL-C. |
Steyn N. et al. (11) 2023 | 64 765 | South Africa |
| Direct chemical assay | Adults with hypertriglyceridemia across 3 hospital sites | The Extended Martin–Hopkins equation correlated better with direct LDL-C than the Sampson-NIH equation on both platforms with TG levels up to 800 mg/dL (9.04 mmol/L). |
Ertürk Zararsız G. et al. (12) 2022 | 3908 | Turkey |
| Direct chemical assays (Roche, Beckman, Siemens) | Pediatric population (age <18 years) undergoing lipid testing | Martin–Hopkins and Extended Martin–Hopkins had the highest concordance coefficient in both overall and all sublevels of LDL-C, non-HDL-C, and TG. |
Naser A. et al. (13) 2022 | 402 | Brazil |
| Direct chemical assay | Patients with diabetes mellitus | Martin–Hopkins and Sampson-NIH equations showed similar accuracy for calculating LDL-C. (Martin–Hopkins 96.3% and Sampson-NIH 96.0% when compared to direct measurement). However, this study is limited by a relatively small sample size. |
Azimi V. et al. (14) 2022 | 934 | USA |
| Direct chemical assay | Adult outpatients and inpatients from a variety of specialties | Martin–Hopkins equation ↓ LDL-C treatment group miscategorization rates leading to ↓ underestimation of risk compared to the Sampson-NIH equation; however, neither was sufficiently accurate to report LDL-C in patients with ↑ TG ≥400 mg/dL (≥4.52 mmol/L). |
Song Y. et al. (15) 2022 | 177 111 | South Korea |
| Direct chemical assay | Asymptomatic adults who underwent lipid testing | Martin–Hopkins outperformed the Sampson-NIH equation with the lowest mean absolute differences across the full spectrum of TG levels, even up to TG values of 500–600 mg/dL (5.64–6.78 mmol/L). |
Sajja A. et al. (16) 2022 | 146 106 | Western USA |
| Not applicable: study assessed discordance between LDL-C equations | Adults with clinical ASCVD and at least 1 lipid panel with a TG level of <400 mg/dL | The Martin–Hopkins equation consistently estimated higher LDL-C values than the Friedewald and Sampson-NIH equations. Discordance rates were clinically meaningful [>10 mg/dL (0.26 mmol/L)], and highest at low LDL-C [<70 mg/dL (<1.81 mmol/L)] and TG levels ≥150 mg/dL (≥1.69 mmol/L). |
Steyn N. et al. (17) 2022 | 64 763 | South Africa |
| Direct chemical assay | Pediatric patients and adult patients with uncontrolled diabetes mellitus |
|
Rossouw H. et al. (18) 2021 | 9995 | South Africa | 11 total equations including:
| Direct chemical assays (Abbott and Roche) | Adult lipid samples analyzed by the Abbott and Roche analyzers | On the Abbott platform there was no difference between the Martin–Hopkins and Sampson-NIH methods; however, with the Roche assay, the Martin–Hopkins method outperformed the Sampson-NIH. The authors suggested the replacement of the Friedewald equation with Martin–Hopkins equation in clinical practice to improve the quality of LDL-C across analyzers, whereas caution was advised regarding the Sampson-NIH equation. |
Sajja A. et al. (7) 2021 | 111 939 | USA |
| VAP ultracentrifugation | Hyperlipidemia:
| The extended Martin–Hopkins equation showed greater LDL-C accuracy compared with the Friedewald and Sampson-NIH equations in patients with TG levels of 400 to 799 mg/dL (4.52–9.02 mmol/L). |
FH, familial hypercholesterolemia; CETP, cholesteryl ester transfer protein.
Summary of high-quality studies comparing various equations for LDL-C calculation since 2020.
First author and Publication year . | Sample size . | Location . | LDL-C equations evaluated . | LDL-C reference method . | Baseline population . | Summary of findings . |
---|---|---|---|---|---|---|
Samuel C. et al. (8) 2023 | 5 051 467 | USA | 23 total equations including:
| VAP ultracentrifugation | Hyperlipidemia:
| Martin–Hopkins was most accurate, followed by the Sampson-NIH, Chen, and Puavilai equations. In addition to the highest overall accuracy, the Martin–Hopkins equation was the top performing equation when stratifying by age, sex, fasting status, and triglyceride levels, as well as in patients with atherosclerotic cardiovascular disease, hypertension, diabetes, kidney disease, inflammation, and thyroid dysfunction. |
Sun C. et al. (9) 2023 | 26 094 | Canada |
| Not applicable: study assessed discordance among LDL-C equations | Hyperlipidemia:
| Both the Martin–Hopkins and the Sampson-NIH equations reclassified patients with ↑ TG and ↓ LDL-C compared to Friedewald. However, the Sampson-NIH equation underestimated LDL-C in patients with FH. |
Martin S.S. et al. (10) 2023 | 364 | Netherlands and Denmark |
| Preparative ultracentrifugation (beta quantification) | Dyslipidemia patients on CETP inhibition in a multicenter randomized controlled trial | Martin–Hopkins was the most accurate, followed by the Sampson-NIH and Friedewald equations. Held true in patients with ↑ TG and ↓ LDL-C. |
Steyn N. et al. (11) 2023 | 64 765 | South Africa |
| Direct chemical assay | Adults with hypertriglyceridemia across 3 hospital sites | The Extended Martin–Hopkins equation correlated better with direct LDL-C than the Sampson-NIH equation on both platforms with TG levels up to 800 mg/dL (9.04 mmol/L). |
Ertürk Zararsız G. et al. (12) 2022 | 3908 | Turkey |
| Direct chemical assays (Roche, Beckman, Siemens) | Pediatric population (age <18 years) undergoing lipid testing | Martin–Hopkins and Extended Martin–Hopkins had the highest concordance coefficient in both overall and all sublevels of LDL-C, non-HDL-C, and TG. |
Naser A. et al. (13) 2022 | 402 | Brazil |
| Direct chemical assay | Patients with diabetes mellitus | Martin–Hopkins and Sampson-NIH equations showed similar accuracy for calculating LDL-C. (Martin–Hopkins 96.3% and Sampson-NIH 96.0% when compared to direct measurement). However, this study is limited by a relatively small sample size. |
Azimi V. et al. (14) 2022 | 934 | USA |
| Direct chemical assay | Adult outpatients and inpatients from a variety of specialties | Martin–Hopkins equation ↓ LDL-C treatment group miscategorization rates leading to ↓ underestimation of risk compared to the Sampson-NIH equation; however, neither was sufficiently accurate to report LDL-C in patients with ↑ TG ≥400 mg/dL (≥4.52 mmol/L). |
Song Y. et al. (15) 2022 | 177 111 | South Korea |
| Direct chemical assay | Asymptomatic adults who underwent lipid testing | Martin–Hopkins outperformed the Sampson-NIH equation with the lowest mean absolute differences across the full spectrum of TG levels, even up to TG values of 500–600 mg/dL (5.64–6.78 mmol/L). |
Sajja A. et al. (16) 2022 | 146 106 | Western USA |
| Not applicable: study assessed discordance between LDL-C equations | Adults with clinical ASCVD and at least 1 lipid panel with a TG level of <400 mg/dL | The Martin–Hopkins equation consistently estimated higher LDL-C values than the Friedewald and Sampson-NIH equations. Discordance rates were clinically meaningful [>10 mg/dL (0.26 mmol/L)], and highest at low LDL-C [<70 mg/dL (<1.81 mmol/L)] and TG levels ≥150 mg/dL (≥1.69 mmol/L). |
Steyn N. et al. (17) 2022 | 64 763 | South Africa |
| Direct chemical assay | Pediatric patients and adult patients with uncontrolled diabetes mellitus |
|
Rossouw H. et al. (18) 2021 | 9995 | South Africa | 11 total equations including:
| Direct chemical assays (Abbott and Roche) | Adult lipid samples analyzed by the Abbott and Roche analyzers | On the Abbott platform there was no difference between the Martin–Hopkins and Sampson-NIH methods; however, with the Roche assay, the Martin–Hopkins method outperformed the Sampson-NIH. The authors suggested the replacement of the Friedewald equation with Martin–Hopkins equation in clinical practice to improve the quality of LDL-C across analyzers, whereas caution was advised regarding the Sampson-NIH equation. |
Sajja A. et al. (7) 2021 | 111 939 | USA |
| VAP ultracentrifugation | Hyperlipidemia:
| The extended Martin–Hopkins equation showed greater LDL-C accuracy compared with the Friedewald and Sampson-NIH equations in patients with TG levels of 400 to 799 mg/dL (4.52–9.02 mmol/L). |
First author and Publication year . | Sample size . | Location . | LDL-C equations evaluated . | LDL-C reference method . | Baseline population . | Summary of findings . |
---|---|---|---|---|---|---|
Samuel C. et al. (8) 2023 | 5 051 467 | USA | 23 total equations including:
| VAP ultracentrifugation | Hyperlipidemia:
| Martin–Hopkins was most accurate, followed by the Sampson-NIH, Chen, and Puavilai equations. In addition to the highest overall accuracy, the Martin–Hopkins equation was the top performing equation when stratifying by age, sex, fasting status, and triglyceride levels, as well as in patients with atherosclerotic cardiovascular disease, hypertension, diabetes, kidney disease, inflammation, and thyroid dysfunction. |
Sun C. et al. (9) 2023 | 26 094 | Canada |
| Not applicable: study assessed discordance among LDL-C equations | Hyperlipidemia:
| Both the Martin–Hopkins and the Sampson-NIH equations reclassified patients with ↑ TG and ↓ LDL-C compared to Friedewald. However, the Sampson-NIH equation underestimated LDL-C in patients with FH. |
Martin S.S. et al. (10) 2023 | 364 | Netherlands and Denmark |
| Preparative ultracentrifugation (beta quantification) | Dyslipidemia patients on CETP inhibition in a multicenter randomized controlled trial | Martin–Hopkins was the most accurate, followed by the Sampson-NIH and Friedewald equations. Held true in patients with ↑ TG and ↓ LDL-C. |
Steyn N. et al. (11) 2023 | 64 765 | South Africa |
| Direct chemical assay | Adults with hypertriglyceridemia across 3 hospital sites | The Extended Martin–Hopkins equation correlated better with direct LDL-C than the Sampson-NIH equation on both platforms with TG levels up to 800 mg/dL (9.04 mmol/L). |
Ertürk Zararsız G. et al. (12) 2022 | 3908 | Turkey |
| Direct chemical assays (Roche, Beckman, Siemens) | Pediatric population (age <18 years) undergoing lipid testing | Martin–Hopkins and Extended Martin–Hopkins had the highest concordance coefficient in both overall and all sublevels of LDL-C, non-HDL-C, and TG. |
Naser A. et al. (13) 2022 | 402 | Brazil |
| Direct chemical assay | Patients with diabetes mellitus | Martin–Hopkins and Sampson-NIH equations showed similar accuracy for calculating LDL-C. (Martin–Hopkins 96.3% and Sampson-NIH 96.0% when compared to direct measurement). However, this study is limited by a relatively small sample size. |
Azimi V. et al. (14) 2022 | 934 | USA |
| Direct chemical assay | Adult outpatients and inpatients from a variety of specialties | Martin–Hopkins equation ↓ LDL-C treatment group miscategorization rates leading to ↓ underestimation of risk compared to the Sampson-NIH equation; however, neither was sufficiently accurate to report LDL-C in patients with ↑ TG ≥400 mg/dL (≥4.52 mmol/L). |
Song Y. et al. (15) 2022 | 177 111 | South Korea |
| Direct chemical assay | Asymptomatic adults who underwent lipid testing | Martin–Hopkins outperformed the Sampson-NIH equation with the lowest mean absolute differences across the full spectrum of TG levels, even up to TG values of 500–600 mg/dL (5.64–6.78 mmol/L). |
Sajja A. et al. (16) 2022 | 146 106 | Western USA |
| Not applicable: study assessed discordance between LDL-C equations | Adults with clinical ASCVD and at least 1 lipid panel with a TG level of <400 mg/dL | The Martin–Hopkins equation consistently estimated higher LDL-C values than the Friedewald and Sampson-NIH equations. Discordance rates were clinically meaningful [>10 mg/dL (0.26 mmol/L)], and highest at low LDL-C [<70 mg/dL (<1.81 mmol/L)] and TG levels ≥150 mg/dL (≥1.69 mmol/L). |
Steyn N. et al. (17) 2022 | 64 763 | South Africa |
| Direct chemical assay | Pediatric patients and adult patients with uncontrolled diabetes mellitus |
|
Rossouw H. et al. (18) 2021 | 9995 | South Africa | 11 total equations including:
| Direct chemical assays (Abbott and Roche) | Adult lipid samples analyzed by the Abbott and Roche analyzers | On the Abbott platform there was no difference between the Martin–Hopkins and Sampson-NIH methods; however, with the Roche assay, the Martin–Hopkins method outperformed the Sampson-NIH. The authors suggested the replacement of the Friedewald equation with Martin–Hopkins equation in clinical practice to improve the quality of LDL-C across analyzers, whereas caution was advised regarding the Sampson-NIH equation. |
Sajja A. et al. (7) 2021 | 111 939 | USA |
| VAP ultracentrifugation | Hyperlipidemia:
| The extended Martin–Hopkins equation showed greater LDL-C accuracy compared with the Friedewald and Sampson-NIH equations in patients with TG levels of 400 to 799 mg/dL (4.52–9.02 mmol/L). |
FH, familial hypercholesterolemia; CETP, cholesteryl ester transfer protein.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.